In a recent study examining neuroimaging biomarkers of Alzheimer’s disease, researchers found that neocortical tau pathology exhibited the strongest association with cognitive decline and the use of tau positron emission tomography (tau-PET) provided the best prognostic value of all neuroimaging modalities in this patient population.

When you are asked for an informal medical opinion, one’s intellectual curiosity and desire to help others never fade away.

Catch up on the top radiology content of the past week.

The use of non-contrast, biparametric MRI (bpMRI) for prostate cancer screening regardless of PSA values detected more clinically significant cases of prostate cancer than reserving bpMRI for patients with elevated PSA levels, according to preliminary findings from an ongoing prospective, randomized study.

Through a new technology add-on payment (NTAP), the use of Cytalux will reportedly be reimbursed by CMS up to 65 percent of the cost of the molecular imaging agent, which is FDA-approved for intraoperative imaging of ovarian and lung cancer.

Emerging research suggests that a high volume of enhancing parenchyma on dynamic contrast-enhanced MRI more than doubles the breast cancer risk for women with extremely dense breasts.

The most common brain MRI findings associated with COVID-19 included acute/subacute infarction in 22 percent of patients and cerebral microbleeds in 17 percent of patients.

The indications for Gadobutrol injection, a generic substitute for Gadavist, include neurovascular and cardiovascular assessments as well as breast malignancy detection with magnetic resonance imaging (MRI).

Review the case study and test your knowledge to make the correct diagnosis.

In a video interview, Hong Song, M.D., Ph.D., discussed retrospective research, presented at the recent Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference, that evaluated the combination of artificial intelligence (AI)-based software and the PSMA agent piflufolastat F 18 to help quantify prostate cancer lesions and associations with biochemical progression-free survival.

Does access to prior imaging results have to be mission impossible for teleradiologists?

The controversial Independent Dispute Resolution (IDR) process of the No Surprises Act was temporarily suspended by the CMS on August 4 due to a federal court ruling that vacated a substantial administrative fee increase and batching rule from the CMS that reportedly curtailed challenges of claim reimbursement by radiologists and other providers.

Catch up on the top radiology content of the past week.

The PET radiotracer 18F-PSMA-1007 facilitated detection of at least one suspicious lesion for metastasis in nearly half of a cohort of 160 patients with prostate cancer, according to research presented recently at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.

In what may represent the first CMS approval of a new technology add-on payment (NTAP) for an artificial intelligence (AI)-based heart failure detection platform, use of the EchoGo Heart Failure system will be eligible for up to $1,023.75 in NTAP reimbursement per acute hospital in-patient stay as of October 1, 2023.

Emerging research suggests that achieving an optimal virtual monoenergetic image (VMI) energy level with photon-counting computed tomography (CT) may allow up to a 40 percent reduction of contrast media dosing for coronary CT angiography.

With reported performance validation on over 17,000 ultrasound images, Sonio Detect employs artificial intelligence (AI) to help ensure quality criteria for fetal ultrasound imaging of the brain and heart.

Reportedly the first randomized trial to examine the impact of artificial intelligence (AI) on screening mammography, researchers found AI-aided screening led to a 20 percent increase in breast cancer detection and a 44.3 percent decrease in mammography screening workload.

Catch up on the top AI-related news and research from the past month.

Review the case study and test your knowledge to make the correct diagnosis.